3.0
3. Jan. 2011
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Novartis used to be the most stable of the large pharma companies to work for. Very ethical company with a strong pipeline.
Kontras
Recently upper management ordered a significant downsizing. The company's multi billion dollar flagship drug is going generic in 2012. Novartis has implemented a hiring freeze for the past several years. Little chance of getting into company right now and little opportunities for promotion.